Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

NCT02059681 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myocardial Ischemia

Interventions

OTHER: Autologous bone marrow derived-CD133+ cells

Sponsor

Centro Cardiologico Monzino

Collaborators

[object Object]
[object Object]